TY - JOUR
T1 - The profile of cognitive impairment and hemodynamic compromise in moyamoya
T2 - a single-center prospective cohort study
AU - Kronenburg, Annick
AU - Deckers, Pieter T.
AU - van den Berg, Esther
AU - van Schooneveld, Monique M.
AU - Vonken, Evert Jan
AU - van der Zwan, Albert
AU - van Berckel, Bart N.M.
AU - Yaqub, Maqsood
AU - Otte, Willem
AU - Klijn, Catharina J.M.
AU - Braun, Kees P.J.
N1 - Funding Information:
Dr. Klijn received grants outside the current work from the Netherlands Cardiovascular Research Initiative, which is supported by the Dutch Heart Foundation (CVON2015-01: CONTRAST), and the support of the Brain Foundation Netherlands (HA2015.01.06). The collaboration project is additionally financed by the Ministry of Economic Affairs by means of the PPP Allowance made available by the Top Sector Life Sciences & Health to stimulate public-private partnerships (LSHM17016). This work was funded in part through unrestricted funding by Stryker, Medtronic, and Cerenovus. The funding sources were not involved in study design, monitoring, data collection, statistical analyses, interpretation of results, or manuscript writing. Radboud UMC and Erasmus UMC received additional unrestricted funding on behalf of CONTRAST for the execution of the Dutch ICH Surgery Trial pilot study from Penumbra, Inc.
Funding Information:
This work was supported by the Dutch Brain Foundation (grant no. 2012[1]-179); the Christine Bader Fund Irene Children’s Hospital; the Tutein Nolthenius Oldenhof Fund; the Johanna Children Fund; Friends of the Wilhelmina Children’s Hospital; and the Brain Technology Institute Foundation. Dr. Klijn is supported by a Clinical Established Investigator grant from the Dutch Heart Foundation (grant no. 2012T077) and an Aspasia grant from ZonMw (i.e., the Netherlands Organization for Health Research and Development, grant no. 015008048).
Publisher Copyright:
©AANS 2023, except where prohibited by US copyright law.
PY - 2023/1
Y1 - 2023/1
N2 - OBJECTIVE Patients with moyamoya vasculopathy often experience cognitive impairments. In this prospective single-center study, the authors investigated the profile of neurocognitive impairment and its relation with the severity of ischemic brain lesions and hemodynamic compromise. METHODS Patients treated in a Dutch tertiary referral center were prospectively included. All patients underwent standardized neuropsychological evaluation, MRI, digital subtraction angiography, and [15O]H2O-PET (to measure cerebrovascular reactivity [CVR]). The authors determined z-scores for 7 cognitive domains and the proportion of patients with cognitive impairment (z-score < −1.5 SD in at least one domain). The authors explored associations between patient characteristics, imaging and CVR findings, and cognitive scores per domain by using multivariable linear regression and Bayesian regression analysis. RESULTS A total of 40 patients (22 children; 75% females) were included. The median age for children was 9 years (range 1–16 years); for adults it was 39 years (range 19–53 years). Thirty patients (75%) had an infarction, and 31 patients (78%) had impaired CVR (steal phenomenon). Six of 7 cognitive domains scored below the population norm. Twenty-nine patients (73%) had cognitive impairment. Adults performed better than children in the cognitive domain visuospatial functioning (p = 0.033, Bayes factor = 4.0), and children performed better in processing speed (p = 0.041, Bayes factor = 3.5). The authors did not find an association between infarction, white matter disease, or CVR and cognitive domains. CONCLUSIONS In this Western cohort, cognitive functioning in patients with moyamoya vasculopathy was below the population norm, and 73% had cognitive impairment in at least one domain. The cognitive profile differed between adults and children. The authors could not find an association with imaging findings.
AB - OBJECTIVE Patients with moyamoya vasculopathy often experience cognitive impairments. In this prospective single-center study, the authors investigated the profile of neurocognitive impairment and its relation with the severity of ischemic brain lesions and hemodynamic compromise. METHODS Patients treated in a Dutch tertiary referral center were prospectively included. All patients underwent standardized neuropsychological evaluation, MRI, digital subtraction angiography, and [15O]H2O-PET (to measure cerebrovascular reactivity [CVR]). The authors determined z-scores for 7 cognitive domains and the proportion of patients with cognitive impairment (z-score < −1.5 SD in at least one domain). The authors explored associations between patient characteristics, imaging and CVR findings, and cognitive scores per domain by using multivariable linear regression and Bayesian regression analysis. RESULTS A total of 40 patients (22 children; 75% females) were included. The median age for children was 9 years (range 1–16 years); for adults it was 39 years (range 19–53 years). Thirty patients (75%) had an infarction, and 31 patients (78%) had impaired CVR (steal phenomenon). Six of 7 cognitive domains scored below the population norm. Twenty-nine patients (73%) had cognitive impairment. Adults performed better than children in the cognitive domain visuospatial functioning (p = 0.033, Bayes factor = 4.0), and children performed better in processing speed (p = 0.041, Bayes factor = 3.5). The authors did not find an association between infarction, white matter disease, or CVR and cognitive domains. CONCLUSIONS In this Western cohort, cognitive functioning in patients with moyamoya vasculopathy was below the population norm, and 73% had cognitive impairment in at least one domain. The cognitive profile differed between adults and children. The authors could not find an association with imaging findings.
KW - cerebral perfusion
KW - cognitive function
KW - determinants
KW - ischemia
KW - moyamoya vasculopathy
KW - neuropsychological evaluation
KW - vascular disorders
UR - http://www.scopus.com/inward/record.url?scp=85144676519&partnerID=8YFLogxK
U2 - 10.3171/2022.3.JNS212844
DO - 10.3171/2022.3.JNS212844
M3 - Article
C2 - 35523260
SN - 0022-3085
VL - 138
SP - 173
EP - 184
JO - Journal of Neurosurgery
JF - Journal of Neurosurgery
IS - 1
ER -